Skip to content

Author

M. Kitakaze

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Effects of low-dose dapagliflozin on heart failure–related outcomes in patients with heart failure and type 2 diabetes: a subanalysis of the dapper study

The efficacy of sodium–glucose cotransporter 2 inhibitors in heart failure (HF) has been well established. Dapagliflozin 10 mg has been shown to improve clinical outcomes in HF in DAPA-HF and DELIVER; however, evidence supporting low-dose dapagliflozin in HF remains limited. This post hoc analysis of the D...

S. Ito, F. Yoshihara, M. Imazu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.